Compare ASMB & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | ELVA |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 359.5M |
| IPO Year | 2010 | 2021 |
| Metric | ASMB | ELVA |
|---|---|---|
| Price | $28.24 | $8.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $43.40 | $14.00 |
| AVG Volume (30 Days) | 92.6K | ★ 434.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.33 | $33.92 |
| Revenue Next Year | N/A | $56.86 |
| P/E Ratio | ★ N/A | $78.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.76 | $2.30 |
| 52 Week High | $39.71 | $11.88 |
| Indicator | ASMB | ELVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.18 | 53.79 |
| Support Level | $26.50 | $8.11 |
| Resistance Level | $30.66 | $9.12 |
| Average True Range (ATR) | 1.46 | 0.52 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 36.74 | 88.20 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.